Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Inclusion Criteria:

- The subject is at least 16 years of age at the time of enrollment and is currently
sexually active (has had penile/vaginal intercourse within the past 12 months)

- The subject and/or legally authorized representative is willing to undergo the
informed consent process prior to study participation (a minor will need the
documented consent of his/her parent or legal guardian, unless the site has an
institutional review board [IRB]-approved waiver for parental consent for minors)

In addition, the subject must meet at least one of the following criteria:

- The subject reports symptoms consistent with a suspected sexually transmissible
infection (STI) such as abnormal discharge, genital itching, pain/discomfort during
sexual intercourse or urination, and/or lower abdominal discomfort

- Subject is asymptomatic and known to be partners with, or a contact of, a person with
a confirmed or suspected STI(s)

- Subject is asymptomatic and undergoing screening evaluation for possible STIs

- Subject is asymptomatic and undergoing a routine examination with a pelvic
examination

Exclusion Criteria:

- The subject took antibiotic medications within the last 21 days

- Subject already participated in this study

- Subject has a history of illness that the principal investigator (PI) or designee
considers could interfere with or affect the conduct, results, and/or completion of
the clinical trial

- Subject has a history of illness that the PI or designee considers could create an
unacceptable risk to the subject if enrolled